You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (AML) (1)

Breast Cancer (1)

Cancer (1)

Multiple Myeloma (1)

Myelofibrosis (MF) (1)

Non-Hodgkins Lymphoma (1)

Non-Small Cell Lung Cancer (1)

Prostate Cancer (1)

Small Cell Lung Cancer (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

AbbVie (2)

Collaborator

Intervention

abbv-075 (1)

mivebresib (1)

navitoclax (1)

ruxolitinib (1)

venetoclax (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

mivebresib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Myelofibrosis (MF) Trial in Korea, Republic of, South Africa, United States (Mivebresib, Navitoclax, Ruxolitinib)

Active, not recruiting

Myelofibrosis (MF)

Mivebresib
+2 more

Stony Brook, New York
+6 more

Mar 23, 2022

Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

Completed

Cancer
+7 more

Scottsdale, Arizona
+9 more

Nov 27, 2019